142 related articles for article (PubMed ID: 29455091)
1. An UPLC-MS/MS method to determine CT-707 and its two metabolites in plasma of ALK-positive advanced non-small cell lung cancer patients.
Cui C; Hu P; Jiang J; Kong F; Luo H; Zhao Q
J Pharm Biomed Anal; 2018 May; 153():1-8. PubMed ID: 29455091
[TBL] [Abstract][Full Text] [Related]
2. Development of an UPLC-MS/MS method for quantification of Avitinib (AC0010) and its five metabolites in human cerebrospinal fluid: Application to a study of the blood-brain barrier penetration rate of non-small cell lung cancer patients.
Wang W; Zheng X; Wang H; Wang L; Jiang J; Hu P
J Pharm Biomed Anal; 2017 May; 139():205-214. PubMed ID: 28285073
[TBL] [Abstract][Full Text] [Related]
3. An LC-MS/MS method for quantification of AC0010, a novel mutant-selective epidermal growth factor receptor (EGFR) inhibitor, and its metabolites in human plasma and the application to a pharmacokinetic study.
Wang L; Zheng X; Wang W; Hu P; Jiang J
J Pharm Biomed Anal; 2017 Jul; 141():9-18. PubMed ID: 28414972
[TBL] [Abstract][Full Text] [Related]
4. A validated UPLC-MS/MS method to determine free and total irinotecan and its two metabolites in human plasma after intravenous administration of irinotecan hydrochloride liposome injection.
Zhuang Q; Liu X; Sun Z; Wang H; Jiang J
J Pharm Biomed Anal; 2019 Jun; 170():112-123. PubMed ID: 30921645
[TBL] [Abstract][Full Text] [Related]
5. Development of HPLC-MS/MS assay for quantitation of ensartinib in human plasma and its application to a pharmacokinetics study in Chinese patients.
Li H; Wang Y; Chen X; Chen C; Cui J; Han Y; Ding L
Biomed Chromatogr; 2023 May; 37(5):e5610. PubMed ID: 36829269
[TBL] [Abstract][Full Text] [Related]
6. Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the EGFR inhibitors afatinib, erlotinib and osimertinib, the ALK inhibitor crizotinib and the VEGFR inhibitor nintedanib in human plasma from non-small cell lung cancer patients.
Reis R; Labat L; Allard M; Boudou-Rouquette P; Chapron J; Bellesoeur A; Thomas-Schoemann A; Arrondeau J; Giraud F; Alexandre J; Vidal M; Goldwasser F; Blanchet B
J Pharm Biomed Anal; 2018 Sep; 158():174-183. PubMed ID: 29883880
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a UPLC-MS/MS method for quantification of osimertinib (AZD9291) and its metabolite AZ5104 in human plasma.
Zheng X; Wang W; Zhang Y; Ma Y; Zhao H; Hu P; Jiang J
Biomed Chromatogr; 2018 Dec; 32(12):e4365. PubMed ID: 30119142
[TBL] [Abstract][Full Text] [Related]
8. Development of an LC-MS/MS method for quantifying two main metabolites of abivertinib in human plasma.
Zheng X; Wang W; Zhang Y; Ma Y; Zhao H; Gao H; Hu P; Jiang J
Biomed Chromatogr; 2020 Feb; 34(2):e4704. PubMed ID: 31629371
[TBL] [Abstract][Full Text] [Related]
9. A sensitive UPLC-MS/MS method for simultaneous determination of eleven bioactive components of Tong-Xie-Yao-Fang decoction in rat biological matrices.
Li TX; Hu L; Zhang MM; Sun J; Qiu Y; Rui JQ; Yang XH
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 944():90-100. PubMed ID: 24295908
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous determination of Guanfu base G and its active metabolites by UPLC-MS/MS in rat plasma and its application to a pharmacokinetic study.
Zhang L; Wang A; Wang X; Zhang Y; Li X; Liu P
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Apr; 957():1-6. PubMed ID: 24636893
[TBL] [Abstract][Full Text] [Related]
11. Development of an LC-MS/MS method for quantifying ASK120067, a novel mutant-selective inhibitor of the epidermal growth factor receptor (EGFR) as well as its main metabolite in human plasma and its application in a pharmacokinetic study.
Cui X; Wang S; Gao H; Li B; Shi Y; Guo H; Song T; Zheng X
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jan; 1162():122488. PubMed ID: 33360679
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous determination of bentysrepinine (Y101) and its metabolites M8 and M9 in human plasma by UPLC-MS/MS and its application to a pharmacokinetic study.
Liu X; Huang C; Xue L; Xu Q; Xia W; Li X; Miao L
J Pharm Biomed Anal; 2018 Feb; 150():287-293. PubMed ID: 29258048
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous and rapid determination of 12 tyrosine kinase inhibitors by LC-MS/MS in human plasma: Application to therapeutic drug monitoring in patients with non-small cell lung cancer.
Zhou L; Wang S; Chen M; Huang S; Zhang M; Bao W; Bao A; Zhang P; Guo H; Liu Z; Xie G; Gao J; Wu Z; Lou Y; Fan G
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1175():122752. PubMed ID: 33991955
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination of erlotinib and tamoxifen in rat plasma using UPLC-MS/MS: Application to pharmacokinetic interaction studies.
Maher HM; Alzoman NZ; Shehata SM
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1028():100-110. PubMed ID: 27336702
[TBL] [Abstract][Full Text] [Related]
15. An UPLC-MS/MS method for the quantitation of alectinib in rat plasma.
Huang XX; Li YX; Li XY; Hu XX; Tang PF; Hu GX
J Pharm Biomed Anal; 2017 Jan; 132():227-231. PubMed ID: 27768922
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of tivantinib in rat plasma using ultra performance liquid chromatography with tandem mass spectrometry.
Bai YL; Yuan HC; Zhang DT; Liu Y; Zhang Y
J Pharm Biomed Anal; 2016 Jul; 126():98-102. PubMed ID: 27179187
[TBL] [Abstract][Full Text] [Related]
17. Determination of kurarinone in rat plasma by UPLC-MS/MS.
Zhang WM; Li RF; Qiu JF; Zhang ZY; Wang HB; Bian L; Lei JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr; 986-987():31-4. PubMed ID: 25703950
[TBL] [Abstract][Full Text] [Related]
18. Development of a UPLC-MS/MS method for quantitation of metronidazole and 2-hydroxy metronidazole in human plasma and its application to a pharmacokinetic study.
Stancil SL; van Haandel L; Abdel-Rahman S; Pearce RE
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():272-278. PubMed ID: 29933220
[TBL] [Abstract][Full Text] [Related]
19. Determination of acacetin in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study.
Fan LH; Li X; Chen DY; Zhang N; Wang Y; Shan Y; Hu Y; Xu RA; Jin J; Ge RS
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr; 986-987():18-22. PubMed ID: 25703948
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous determination of dacomitinib and its major metabolite, O-desmethyl dacomitinib in human plasma by LC-MS/MS and its application to clinical testing in patients with non-small cell lung cancer.
Feng X; Ding Y; Zhang P; Fu Q; Zhang L; Zheng H
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Oct; 1182():122940. PubMed ID: 34564058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
